Engineered exosomes: A new promise for the management of musculoskeletal diseases

Daniele Bellavia, Lavinia Raimondi, Viviana Costa, Angela De Luca, Valeria Carina, Melania Maglio, Milena Fini, R. Alessandro, Gianluca Giavaresi

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Background: Exosomes are nanovesicles actively secreted by potentially all cell types, including tumour cells, with the primary role of extracellular systemic communication mediators, both at autocrine and paracrine levels, at short and long distances. Recently, different studies have used exosomes as a delivery system for a plethora of different molecules, such as drugs, microRNAs and proteins. This has been made possible thanks to the simplicity in exosomes engineering, their great stability and versatility for applications in oncology as well as in regenerative medicine. Scope of review: The aim of this review is to provide information on the state-of-the-art and possible applications of engineered exosomes, both for cargo and specific cell-targeting, in different pathologies related to the musculoskeletal system. Major conclusions: The use of exosomes as therapeutic agents is rapidly evolving, different studies explore drug delivery with exosomes using different molecules, showing an enormous potential in various research fields such as oncology and regenerative medicine. General significance: However, despite the significant progress made by the different studies carried out, currently, the use of exosomes is not a therapeutic reality for the considerable difficulties to overcome.

Original languageEnglish
Pages (from-to)1893-1901
Number of pages9
JournalBiochimica et Biophysica Acta - General Subjects
Volume1862
Issue number9
DOIs
Publication statusPublished - Sep 1 2018

Fingerprint

Musculoskeletal Diseases
Exosomes
Oncology
Musculoskeletal system
Molecules
Pathology
MicroRNAs
Drug delivery
Tumors
Cells
Regenerative Medicine
Communication
Pharmaceutical Preparations
Proteins
Musculoskeletal System
Therapeutics

Keywords

  • Drug delivery
  • Engineered exosomes
  • Immune system regulation
  • Musculoskeletal diseases
  • Oncology
  • Regenerative medicine

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology

Cite this

Engineered exosomes: A new promise for the management of musculoskeletal diseases. / Bellavia, Daniele; Raimondi, Lavinia; Costa, Viviana; De Luca, Angela; Carina, Valeria; Maglio, Melania; Fini, Milena; Alessandro, R.; Giavaresi, Gianluca.

In: Biochimica et Biophysica Acta - General Subjects, Vol. 1862, No. 9, 01.09.2018, p. 1893-1901.

Research output: Contribution to journalReview article

Bellavia, Daniele ; Raimondi, Lavinia ; Costa, Viviana ; De Luca, Angela ; Carina, Valeria ; Maglio, Melania ; Fini, Milena ; Alessandro, R. ; Giavaresi, Gianluca. / Engineered exosomes: A new promise for the management of musculoskeletal diseases. In: Biochimica et Biophysica Acta - General Subjects. 2018 ; Vol. 1862, No. 9. pp. 1893-1901.
@article{411299d1af7b4dd5a1713d02703cfcf6,
title = "Engineered exosomes: A new promise for the management of musculoskeletal diseases",
abstract = "Background: Exosomes are nanovesicles actively secreted by potentially all cell types, including tumour cells, with the primary role of extracellular systemic communication mediators, both at autocrine and paracrine levels, at short and long distances. Recently, different studies have used exosomes as a delivery system for a plethora of different molecules, such as drugs, microRNAs and proteins. This has been made possible thanks to the simplicity in exosomes engineering, their great stability and versatility for applications in oncology as well as in regenerative medicine. Scope of review: The aim of this review is to provide information on the state-of-the-art and possible applications of engineered exosomes, both for cargo and specific cell-targeting, in different pathologies related to the musculoskeletal system. Major conclusions: The use of exosomes as therapeutic agents is rapidly evolving, different studies explore drug delivery with exosomes using different molecules, showing an enormous potential in various research fields such as oncology and regenerative medicine. General significance: However, despite the significant progress made by the different studies carried out, currently, the use of exosomes is not a therapeutic reality for the considerable difficulties to overcome.",
keywords = "Drug delivery, Engineered exosomes, Immune system regulation, Musculoskeletal diseases, Oncology, Regenerative medicine",
author = "Daniele Bellavia and Lavinia Raimondi and Viviana Costa and {De Luca}, Angela and Valeria Carina and Melania Maglio and Milena Fini and R. Alessandro and Gianluca Giavaresi",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/j.bbagen.2018.06.003",
language = "English",
volume = "1862",
pages = "1893--1901",
journal = "Biochimica et Biophysica Acta - General Subjects",
issn = "0304-4165",
publisher = "Elsevier",
number = "9",

}

TY - JOUR

T1 - Engineered exosomes: A new promise for the management of musculoskeletal diseases

AU - Bellavia, Daniele

AU - Raimondi, Lavinia

AU - Costa, Viviana

AU - De Luca, Angela

AU - Carina, Valeria

AU - Maglio, Melania

AU - Fini, Milena

AU - Alessandro, R.

AU - Giavaresi, Gianluca

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Background: Exosomes are nanovesicles actively secreted by potentially all cell types, including tumour cells, with the primary role of extracellular systemic communication mediators, both at autocrine and paracrine levels, at short and long distances. Recently, different studies have used exosomes as a delivery system for a plethora of different molecules, such as drugs, microRNAs and proteins. This has been made possible thanks to the simplicity in exosomes engineering, their great stability and versatility for applications in oncology as well as in regenerative medicine. Scope of review: The aim of this review is to provide information on the state-of-the-art and possible applications of engineered exosomes, both for cargo and specific cell-targeting, in different pathologies related to the musculoskeletal system. Major conclusions: The use of exosomes as therapeutic agents is rapidly evolving, different studies explore drug delivery with exosomes using different molecules, showing an enormous potential in various research fields such as oncology and regenerative medicine. General significance: However, despite the significant progress made by the different studies carried out, currently, the use of exosomes is not a therapeutic reality for the considerable difficulties to overcome.

AB - Background: Exosomes are nanovesicles actively secreted by potentially all cell types, including tumour cells, with the primary role of extracellular systemic communication mediators, both at autocrine and paracrine levels, at short and long distances. Recently, different studies have used exosomes as a delivery system for a plethora of different molecules, such as drugs, microRNAs and proteins. This has been made possible thanks to the simplicity in exosomes engineering, their great stability and versatility for applications in oncology as well as in regenerative medicine. Scope of review: The aim of this review is to provide information on the state-of-the-art and possible applications of engineered exosomes, both for cargo and specific cell-targeting, in different pathologies related to the musculoskeletal system. Major conclusions: The use of exosomes as therapeutic agents is rapidly evolving, different studies explore drug delivery with exosomes using different molecules, showing an enormous potential in various research fields such as oncology and regenerative medicine. General significance: However, despite the significant progress made by the different studies carried out, currently, the use of exosomes is not a therapeutic reality for the considerable difficulties to overcome.

KW - Drug delivery

KW - Engineered exosomes

KW - Immune system regulation

KW - Musculoskeletal diseases

KW - Oncology

KW - Regenerative medicine

UR - http://www.scopus.com/inward/record.url?scp=85048726736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048726736&partnerID=8YFLogxK

U2 - 10.1016/j.bbagen.2018.06.003

DO - 10.1016/j.bbagen.2018.06.003

M3 - Review article

VL - 1862

SP - 1893

EP - 1901

JO - Biochimica et Biophysica Acta - General Subjects

JF - Biochimica et Biophysica Acta - General Subjects

SN - 0304-4165

IS - 9

ER -